# Ultrasound-guided H-FICB for Arthroscopic Knee Surgery： What is the Optimal Dose of Dexmedetomidine?

> **NCT05533970** · NA · COMPLETED · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 120 (actual)

## Conditions studied

- Knee Disease
- Quality of Recovery

## Interventions

- **PROCEDURE:** ultrasound-guided high fascia iliaca compartment block

## Key facts

- **NCT ID:** NCT05533970
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-01-02
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05533970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05533970, "Ultrasound-guided H-FICB for Arthroscopic Knee Surgery： What is the Optimal Dose of Dexmedetomidine?". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05533970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*